SLU-PP-332 is a small-molecule research compound, not a peptide, studied in preclinical research as an agonist of the estrogen-related receptors (ERRs), a family of orphan nuclear receptors. It is examined in in-vitro receptor assays and animal models, most often in the context of mitochondrial-function and cellular-respiration research in skeletal-muscle cell lines.
Because it is a small organic molecule rather than an amino-acid chain, SLU-PP-332 has no peptide sequence; it is identified by its molecular formula, SMILES string, CAS number, and PubChem CID. As supplied by Vantage Aminos for research, it is a prepared solution at 250 mcg/mL, ready to use without reconstitution.
Verified dataVerified compound data
| Property | Value |
|---|---|
| Compound name | SLU-PP-332 |
| Compound class | Small molecule (ERR agonist); NOT a peptide |
| CAS number | 303760-60-3 |
| PubChem CID | 5404083 |
| Molecular formula | C18H14N2O2 |
| Molecular weight | ~290.3 g/mol |
| SMILES | OC1=CC=C(C=C1)C(N/N=C/C2=CC3=C(C=C2)C=CC=C3)=O |
| Amino acid sequence | None: small molecule, not a peptide |
| Physical form (neat compound) | Solid |
| As supplied | Prepared solution, 250 mcg/mL |
Data verified against PubChem (CID 5404083, C18H14N2O2, MW ~290.3) and ChemicalBook / MedChemExpress (CAS 303760-60-3).
MechanismResearch-context mechanism
In preclinical literature, SLU-PP-332 is studied as an agonist of the estrogen-related receptors (ERRα, ERRβ, ERRγ), with the strongest reported activity at ERRα in in-vitro receptor assays. Research has examined its association with mitochondrial-function and cellular-respiration endpoints in skeletal-muscle cell lines and animal models. These interactions are described at the receptor and cellular level in research models only; they are not established human-use mechanisms and describe no human outcome.
Research summaryCurrent research summary
SLU-PP-332 appears in a nuclear-receptor pharmacology research literature focused on ERR agonism. Reported research areas include:
- ERRα / ERRβ / ERRγ receptor-agonism assays (in vitro)
- Mitochondrial-function and cellular-respiration studies in muscle cell lines
- Metabolic-gene-expression research models (e.g., Pdk4)
- Animal-model metabolic-pathway studies
The existing body of work is predominantly in vitro and rodent. There are no large controlled human clinical trials establishing the compound for any therapeutic use, and it is not an FDA-approved drug. All framing here is strictly laboratory research.
QuestionsFrequently Asked Questions
What is SLU-PP-332?
SLU-PP-332 is a small-molecule research compound, not a peptide, studied in preclinical research as an agonist of the estrogen-related receptors (ERRs). It is supplied as a prepared solution at 250 mcg/mL and is not approved for human use.
Is SLU-PP-332 a peptide?
No. SLU-PP-332 is a small organic molecule. It has no amino-acid sequence and is identified by its molecular formula (C18H14N2O2), SMILES, CAS number (303760-60-3), and PubChem CID 5404083.
What is the molecular formula and weight of SLU-PP-332?
The molecular formula of SLU-PP-332 is C18H14N2O2 with a molecular weight of approximately 290.3 g/mol (PubChem CID 5404083).
What is the CAS number for SLU-PP-332?
The CAS registry number for SLU-PP-332 is 303760-60-3.
How is SLU-PP-332 stored in a research setting?
SLU-PP-332 is stored at 2 to 8°C, protected from light. It is supplied ready to use, so no reconstitution is required, and repeated freeze-thaw cycles are avoided.
Is SLU-PP-332 approved for human use?
No. SLU-PP-332 is not an FDA-approved drug and is not intended for human consumption. It is offered strictly as a research compound for laboratory use.
For research use only. Not for human or veterinary use. Not approved by the FDA. 21+
- HPLC + MS tested, every batch
- U.S. synthesized
- Batch COA on the product page
$125View compound